Select a Region North America

Expertise

Scott Snyder

Chief Digital Officer

Expertise:

Commercialization, Data & Analytics, Digital Health, Digital Technology, Emerging Technology, Leadership, RWE, Stakeholder Engagement & Promotion (Patients, Payers, Providers)

Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both global 1000 companies and startup ventures. Scott is an industry expert on how enterprises can leverage digital and other emerging technologies to accelerate innovation and new venture creation. He has held executive positions with several Fortune 500 companies and has been a featured thought leader in publications including CIO, WIRED, Forbes, Knowledge@Wharton, Los Angeles Times and The Wall Street Journal. Scott is also the co-author of Goliath’s Revenge, a book focused on how established companies can turn the table through digital disruption.

He earned his B.S., M.S., and Ph.D. in Systems Engineering from the University of Pennsylvania. Scott is currently a Senior Fellow in the Management Department at the Wharton School.

Articles by Scott Snyder

A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022

By applying transformative commercialization models, nurturing digital transformation and trailblazing in global expansion, we can get therapies to patients around the world who are still waiting for treatment options. For the past two years, the pharmaceutical industry has proven that it can adapt to change. In 2020, pharma pivoted to manage the coronavirus pandemic, and […]

The Power to Know When: Balancing High-Tech and High-Touch Solutions to Eliminate Access, Affordability and Adherence Barriers

Forty percent of consumers prefer speaking to a real person on the phone, and for more complex issues, 80% want to speak to a live service agent. In the increasingly virtual world we live in, one thing remains clear: we still crave human interactions. As a result, pharma manufacturers need to understand how patients and […]

Options and Insights for Successful Development and Launch

Pharma Sponsored Digital Health Solutions and Digital Therapeutics (DTx): Options and Insights for Successful Development and Launch Listen to EVERSANA’s Scott Snyder and Jim O’Donoghue of S3 Connected Health in this recorded webinar as they share insights on the driving forces behind the different types of digital health solutions and #DTx and provide actionable advice on what to consider when […]

Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer

Nearly 32% of Americans suffer from complex, chronic or rare conditions, such as autoimmune diseases, genetic disorders or cancer, many of which require a specialty prescription therapy. Despite being only 3% of overall prescriptions, specialty medications represent nearly 50% of the overall prescription drug spend in the U.S. While we have moved to the on-demand […]

Disrupting Healthcare from the Inside: How Incumbents Can Lead Change

The following opinion piece was written by Scott Snyder, Chief Digital Officer, for Knowledge@Wharton. Outsider attempts to reinvent healthcare have done little to move the needle despite billions invested in promising concepts like Microsoft’s HealthVault, IBM’s Watson Health, Theranos, Google’s Contact Lens, Drugstore.com, and more recently Helix and Haven. These were backed by some of […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.